Cargando…
114. Prospective Trial of Passive Diversion Device to Reduce Blood Culture Contamination
BACKGROUND: Blood culture contaminants can lead to inappropriate antibiotic use, prolonged length of stay, and additional hospital costs. Several devices have been developed to reduce the risk of blood culture contamination by diverting a portion of the initial blood sample from the blood culture bo...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644678/ http://dx.doi.org/10.1093/ofid/ofab466.114 |
_version_ | 1784610141065183232 |
---|---|
author | Arnaout, Sami Ellison, Richard T Greenough, Thomas C Wedig, Azalea Mitchell, Michael J John, Lauren St Stock, Shannon |
author_facet | Arnaout, Sami Ellison, Richard T Greenough, Thomas C Wedig, Azalea Mitchell, Michael J John, Lauren St Stock, Shannon |
author_sort | Arnaout, Sami |
collection | PubMed |
description | BACKGROUND: Blood culture contaminants can lead to inappropriate antibiotic use, prolonged length of stay, and additional hospital costs. Several devices have been developed to reduce the risk of blood culture contamination by diverting a portion of the initial blood sample from the blood culture bottle. We have assessed the effectiveness of one blood diversion device in a prospective trial performed at the two separate emergency departments (EDs) of a three-campus Academic Medical Center. METHODS: A multi-phase prospective crossover trial was performed with the blood diversion device initially in use at one ED (Memorial) and standard equipment at the other ED (University) for 10 weeks. After a washout phase, a second 10-week study phase used the blood diversion device in the other ED (University) and standard equipment at the first ED (Memorial). Contaminants were identified by the clinical microbiology lab using standard criteria, and further defined by independent retrospective review by 3 infectious disease physicians prior to statistical analysis. An intention-to-treat analysis was performed, and Chi-square tests were used to compare contaminant rates among samples obtained using the blood diversion device versus standard equipment. RESULTS: 5,675 blood samples were obtained with 5,661 samples analyzed after 14 were deemed inconclusive by the ID physician review. There were 1,719 samples obtained at Memorial ED and 3,942 at University ED, with 2,836 samples collected during diversion device periods and 2,825 during standard equipment periods. Based on the ID physician review, the contaminant rates were 1.9% in diversion device periods versus 2.9% in standard equipment periods (P = 0.018). There was a marked difference in blood culture contamination rates between the two EDs with contaminant rates at the Memorial ED of 1.1% and 1.4% (P=0.57), and at the University ED of 2.3% and 3.5% (P=0.024) for the diversion device and standard equipment periods, respectively. CONCLUSION: The blood diversion device was able to significantly lower blood culture contamination rates overall by 1% at the institution’s two EDs (34% relative reduction), with a stronger effect noted at the campus with both a level 1 trauma center and transplant programs. DISCLOSURES: All Authors: No reported disclosures |
format | Online Article Text |
id | pubmed-8644678 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-86446782021-12-06 114. Prospective Trial of Passive Diversion Device to Reduce Blood Culture Contamination Arnaout, Sami Ellison, Richard T Greenough, Thomas C Wedig, Azalea Mitchell, Michael J John, Lauren St Stock, Shannon Open Forum Infect Dis Oral Abstracts BACKGROUND: Blood culture contaminants can lead to inappropriate antibiotic use, prolonged length of stay, and additional hospital costs. Several devices have been developed to reduce the risk of blood culture contamination by diverting a portion of the initial blood sample from the blood culture bottle. We have assessed the effectiveness of one blood diversion device in a prospective trial performed at the two separate emergency departments (EDs) of a three-campus Academic Medical Center. METHODS: A multi-phase prospective crossover trial was performed with the blood diversion device initially in use at one ED (Memorial) and standard equipment at the other ED (University) for 10 weeks. After a washout phase, a second 10-week study phase used the blood diversion device in the other ED (University) and standard equipment at the first ED (Memorial). Contaminants were identified by the clinical microbiology lab using standard criteria, and further defined by independent retrospective review by 3 infectious disease physicians prior to statistical analysis. An intention-to-treat analysis was performed, and Chi-square tests were used to compare contaminant rates among samples obtained using the blood diversion device versus standard equipment. RESULTS: 5,675 blood samples were obtained with 5,661 samples analyzed after 14 were deemed inconclusive by the ID physician review. There were 1,719 samples obtained at Memorial ED and 3,942 at University ED, with 2,836 samples collected during diversion device periods and 2,825 during standard equipment periods. Based on the ID physician review, the contaminant rates were 1.9% in diversion device periods versus 2.9% in standard equipment periods (P = 0.018). There was a marked difference in blood culture contamination rates between the two EDs with contaminant rates at the Memorial ED of 1.1% and 1.4% (P=0.57), and at the University ED of 2.3% and 3.5% (P=0.024) for the diversion device and standard equipment periods, respectively. CONCLUSION: The blood diversion device was able to significantly lower blood culture contamination rates overall by 1% at the institution’s two EDs (34% relative reduction), with a stronger effect noted at the campus with both a level 1 trauma center and transplant programs. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2021-12-04 /pmc/articles/PMC8644678/ http://dx.doi.org/10.1093/ofid/ofab466.114 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Oral Abstracts Arnaout, Sami Ellison, Richard T Greenough, Thomas C Wedig, Azalea Mitchell, Michael J John, Lauren St Stock, Shannon 114. Prospective Trial of Passive Diversion Device to Reduce Blood Culture Contamination |
title | 114. Prospective Trial of Passive Diversion Device to Reduce Blood Culture Contamination |
title_full | 114. Prospective Trial of Passive Diversion Device to Reduce Blood Culture Contamination |
title_fullStr | 114. Prospective Trial of Passive Diversion Device to Reduce Blood Culture Contamination |
title_full_unstemmed | 114. Prospective Trial of Passive Diversion Device to Reduce Blood Culture Contamination |
title_short | 114. Prospective Trial of Passive Diversion Device to Reduce Blood Culture Contamination |
title_sort | 114. prospective trial of passive diversion device to reduce blood culture contamination |
topic | Oral Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644678/ http://dx.doi.org/10.1093/ofid/ofab466.114 |
work_keys_str_mv | AT arnaoutsami 114prospectivetrialofpassivediversiondevicetoreducebloodculturecontamination AT ellisonrichardt 114prospectivetrialofpassivediversiondevicetoreducebloodculturecontamination AT greenoughthomasc 114prospectivetrialofpassivediversiondevicetoreducebloodculturecontamination AT wedigazalea 114prospectivetrialofpassivediversiondevicetoreducebloodculturecontamination AT mitchellmichaelj 114prospectivetrialofpassivediversiondevicetoreducebloodculturecontamination AT johnlaurenst 114prospectivetrialofpassivediversiondevicetoreducebloodculturecontamination AT stockshannon 114prospectivetrialofpassivediversiondevicetoreducebloodculturecontamination |